色素沈着症治療の世界市場規模、シェア、産業動向分析レポート：タイプ別、治療法別、流通チャネル別、地域別展望と予測、2023年～2030年

色素沈着症治療市場規模は、予測期間中にCAGR 4.8％で成長し、2030年までに12億米ドルに達すると予測されます。

しかし、現在利用可能な色素沈着症治療オプションの有効性が限定的であることは、皮膚科領域における重大な懸念事項です。この限界の主な要因の一つは、これらの症状が複雑かつ多面的であることです。色素沈着症は多くの場合、皮膚内の複雑なメカニズムが関与しているため、直接的な治療アプローチが困難です。その結果、万能の解決策はなく、効果的な治療法の探求は皮膚科医や研究者を悩ませ続けています。さらに、パンデミックは、スキンケア製品や皮膚科学機器の生産・流通を含む世界のサプライチェーンを混乱させました。このため、特定の治療製品が不足し、新しい治療法の入手が遅れました。パンデミックによって引き起こされた経済的不確実性により、一部の個人は化粧品や皮膚科治療への支出を含む裁量的支出を減らしました。このような経済的影響は、色素沈着症治療薬の値ごろ感と需要に影響を与えました。

タイプ別展望

タイプ別では、市場は白斑、肝斑、その他に分類されます。2022年には、白斑分野が市場で最も高い売上シェアを占めました。白斑は、皮膚の特定部位におけるメラノサイト（色素産生細胞）の消失を特徴とする特異的な色素障害であり、その結果、白い斑点が発生します。白斑の治療は広範な市場の重要な構成要素です。局所コルチコステロイド、カルシニューリン阻害剤、局所カルシポトリエンが一般的に白斑を治療します。これらの製品は皮膚の患部に直接塗布して炎症を抑え、色素沈着を促します。これらは市場において必要不可欠なものです。

治療の展望

治療法に基づき、市場はコルチコステロイド、カルシニューリン阻害薬、その他に区分されます。カルシニューリン阻害剤セグメントは、2022年の市場で大きな収益シェアを獲得しました。カルシニューリン阻害剤は、特に皮膚の菲薄化やその他の懸念のために副腎皮質ステロイドが適さないような地域において、白斑のような色素沈着障害を効果的に治療してきました。これらの薬剤は、皮膚の免疫反応を調節することによって作用し、自己免疫性あるいは炎症性の要素を持つ色素沈着障害に特に有用です。カルシニューリン阻害剤は一般に、顔や生殖器のようなデリケートで敏感な皮膚部位への長期使用には安全であると考えられており、副腎皮質ステロイドでは副作用のリスクが高くなる可能性があります。

流通チャネルの展望

流通チャネル別に見ると、市場は病院薬局、ドラッグストア・小売薬局、オンライン薬局に分けられます。ドラッグストア・小売薬局セグメントは、2022年の市場で最大の売上シェアを記録しました。ドラッグストアや小売薬局では通常、色素沈着障害用の製品を含むさまざまなOTCスキンケア製品を提供しています。このように利用しやすくなったことで、処方箋なしで特定の治療法を調べたり試したりすることができるようになり、これらの製品の売上を押し上げる可能性があります。局所コルチコステロイド、カルシニューリン阻害剤、特殊クリームなど、処方箋による色素沈着症治療の多くは、小売薬局で調剤することができます。

地域別展望

地域別に見ると、市場は北米、欧州、アジア太平洋、LAMEAで分析されます。2022年には、北米地域が最も高い収益シェアを獲得して市場をリードしました。皮膚科クリニックとメディカル・スパは、北米における色素沈着症治療の主要な提供者です。これらの施設は、診察、院内での処置、スキンケア製品など様々なサービスを提供しています。多くの皮膚科クリニックや十分な訓練を受けた皮膚科医を含む北米の確立されたヘルスケア・インフラが市場の成長を支えました。レーザー技術や革新的な治療機器の進歩は、北米における色素沈着症治療の有効性と安全性を高めました。

目次

第1章 市場範囲と調査手法

• 市場の定義
• 目的
• 市場範囲
• セグメンテーション
• 調査手法

第2章 市場の概要

• 主なハイライト

第3章 市場概要

• イントロダクション
  • 概要
    • 市場構成とシナリオ
• 市場に影響を与える主な要因
  • 市場促進要因
  • 市場抑制要因
• ポーターファイブフォース分析

第4章 世界の色素沈着障害治療市場：タイプ別

• 世界の白斑市場：地域別
• 世界の肝斑市場：地域別
• 世界のその他の市場：地域別

第5章 世界の市場：、治療別

• 世界のコルチコステロイド市場：地域別
• 世界のカルシニューリン阻害剤市場：地域別
• 世界のその他の市場：地域別

第6章 世界の市場：、流通チャネル別

• 世界のドラッグストアおよび小売薬局市場：地域別
• 世界の病院薬局市場：地域別
• 世界のオンライン薬局市場：地域別

第7章 世界の市場：、地域別

• 北米の市場
  • 北米の市場：タイプ別
    • 北米の国別白斑市場
    • 国別の北米肝斑市場
    • 北米その他の国別市場
  • 北米の市場治療別
    • 国別の北米コルチコステロイド市場
    • 北米の国別カルシニューリン阻害剤市場
    • 北米その他の国別市場
  • 北米の市場：流通チャネル別
    • 北米の国別ドラッグストアおよび小売薬局市場
    • 北米の国別病院薬局市場
    • 北米の国別オンライン薬局市場
  • 北米の市場：国別
    • 米国の色素沈着障害治療市場
    • カナダの色素沈着障害治療市場
    • メキシコの色素沈着障害治療市場
    • 残りの北米の市場
• 欧州の市場
  • 欧州の市場：タイプ別
    • 欧州の国別白斑市場
    • 国別の欧州肝斑市場
    • 欧州その他の国別市場
  • 欧州の市場治療別
    • 国別の欧州コルチコステロイド市場
    • 欧州の国別カルシニューリン阻害剤市場
    • 欧州その他の国別市場
  • 欧州の市場：流通チャネル別
    • 欧州の国別ドラッグストアおよび小売薬局市場
    • 欧州の国別病院薬局市場
    • 欧州の国別オンライン薬局市場
  • 欧州の市場：国別
    • ドイツの色素沈着疾患治療市場
    • 英国の色素沈着障害治療市場
    • フランスの色素沈着障害治療市場
    • ロシアの色素沈着障害治療市場
    • スペインの色素沈着疾患治療市場
    • イタリアの色素沈着障害治療市場
    • 残りの欧州の市場
• アジア太平洋の市場
  • アジア太平洋の市場：タイプ別
    • アジア太平洋地域の国別白斑市場
    • アジア太平洋地域の国別肝斑市場
    • アジア太平洋地域その他の国別市場
  • アジア太平洋の市場治療別
    • アジア太平洋地域の国別コルチコステロイド市場
    • アジア太平洋地域の国別カルシニューリン阻害剤市場
    • アジア太平洋地域その他の国別市場
  • アジア太平洋の市場：流通チャネル別
    • アジア太平洋地域の国別ドラッグストアおよび小売薬局市場
    • アジア太平洋地域の病院薬局市場：（国別）
    • アジア太平洋地域の国別オンライン薬局市場
  • アジア太平洋の市場：国別
    • 中国の色素沈着障害治療市場
    • 日本の色素沈着疾患治療市場
    • インドの色素沈着障害治療市場
    • 韓国の色素沈着疾患治療市場
    • シンガポールの色素沈着障害治療市場
    • マレーシアの色素沈着障害治療市場
    • 残りのアジア太平洋の市場
• ラテンアメリカ・中東・アフリカの市場
  • ラテンアメリカ・中東・アフリカの市場：タイプ別
    • 国別LAMEA白斑市場
    • 国別LAMEA肝斑市場
    • 国別LAMEAその他市場
  • ラテンアメリカ・中東・アフリカの市場治療別
    • 国別のLAMEAコルチコステロイド市場
    • 国別のLAMEAカルシニューリン阻害剤市場
    • 国別LAMEAその他市場
  • ラテンアメリカ・中東・アフリカの市場：流通チャネル別
    • 国別のLAMEAドラッグストアおよび小売薬局市場
    • 国別のLAMEA病院薬局市場
    • 国別のLAMEAオンライン薬局市場
  • ラテンアメリカ・中東・アフリカの市場：国別
    • ブラジルの色素沈着障害治療市場
    • アルゼンチンの色素沈着障害治療市場
    • アラブ首長国連邦の色素沈着障害治療市場
    • サウジアラビアの色素沈着障害治療市場
    • 南アフリカの色素沈着障害治療市場
    • ナイジェリアの色素沈着障害治療市場
    • 残りのラテンアメリカ・中東・アフリカの市場

第8章 企業プロファイル

• Bausch Health Companies Inc
• Glenmark Pharmaceuticals Limited
• Obagi Cosmeceuticals LLC
• AbbVie, Inc
• Dermavant Sciences, Inc（Roivant Sciences Ltd.）
• Incyte Corporation
• Dr Reddy's Laboratories Ltd.
• Galderma SA
• Viatris, Inc（Mylan N.V.）
• Pfizer, Inc

第9章 色素沈着障害治療市場の勝利の必須事項

LIST OF TABLES

• TABLE 1 Global Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 2 Global Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 3 Global Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
• TABLE 4 Global Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
• TABLE 5 Global Vitiligo Market, By Region, 2019 - 2022, USD Million
• TABLE 6 Global Vitiligo Market, By Region, 2023 - 2030, USD Million
• TABLE 7 Global Melasma Market, By Region, 2019 - 2022, USD Million
• TABLE 8 Global Melasma Market, By Region, 2023 - 2030, USD Million
• TABLE 9 Global Others Market, By Region, 2019 - 2022, USD Million
• TABLE 10 Global Others Market, By Region, 2023 - 2030, USD Million
• TABLE 11 Global Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
• TABLE 12 Global Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
• TABLE 13 Global Corticosteroids Market, By Region, 2019 - 2022, USD Million
• TABLE 14 Global Corticosteroids Market, By Region, 2023 - 2030, USD Million
• TABLE 15 Global Calcineurin Inhibitor Market, By Region, 2019 - 2022, USD Million
• TABLE 16 Global Calcineurin Inhibitor Market, By Region, 2023 - 2030, USD Million
• TABLE 17 Global Others Market, By Region, 2019 - 2022, USD Million
• TABLE 18 Global Others Market, By Region, 2023 - 2030, USD Million
• TABLE 19 Global Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
• TABLE 20 Global Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
• TABLE 21 Global Drug Store & Retail Pharmacies Market, By Region, 2019 - 2022, USD Million
• TABLE 22 Global Drug Store & Retail Pharmacies Market, By Region, 2023 - 2030, USD Million
• TABLE 23 Global Hospital Pharmacies Market, By Region, 2019 - 2022, USD Million
• TABLE 24 Global Hospital Pharmacies Market, By Region, 2023 - 2030, USD Million
• TABLE 25 Global Online Pharmacies Market, By Region, 2019 - 2022, USD Million
• TABLE 26 Global Online Pharmacies Market, By Region, 2023 - 2030, USD Million
• TABLE 27 Global Pigmentation Disorder Treatment Market, By Region, 2019 - 2022, USD Million
• TABLE 28 Global Pigmentation Disorder Treatment Market, By Region, 2023 - 2030, USD Million
• TABLE 29 North America Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 30 North America Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 31 North America Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
• TABLE 32 North America Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
• TABLE 33 North America Vitiligo Market, By Country, 2019 - 2022, USD Million
• TABLE 34 North America Vitiligo Market, By Country, 2023 - 2030, USD Million
• TABLE 35 North America Melasma Market, By Country, 2019 - 2022, USD Million
• TABLE 36 North America Melasma Market, By Country, 2023 - 2030, USD Million
• TABLE 37 North America Others Market, By Country, 2019 - 2022, USD Million
• TABLE 38 North America Others Market, By Country, 2023 - 2030, USD Million
• TABLE 39 North America Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
• TABLE 40 North America Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
• TABLE 41 North America Corticosteroids Market, By Country, 2019 - 2022, USD Million
• TABLE 42 North America Corticosteroids Market, By Country, 2023 - 2030, USD Million
• TABLE 43 North America Calcineurin Inhibitor Market, By Country, 2019 - 2022, USD Million
• TABLE 44 North America Calcineurin Inhibitor Market, By Country, 2023 - 2030, USD Million
• TABLE 45 North America Others Market, By Country, 2019 - 2022, USD Million
• TABLE 46 North America Others Market, By Country, 2023 - 2030, USD Million
• TABLE 47 North America Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
• TABLE 48 North America Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
• TABLE 49 North America Drug Store & Retail Pharmacies Market, By Country, 2019 - 2022, USD Million
• TABLE 50 North America Drug Store & Retail Pharmacies Market, By Country, 2023 - 2030, USD Million
• TABLE 51 North America Hospital Pharmacies Market, By Country, 2019 - 2022, USD Million
• TABLE 52 North America Hospital Pharmacies Market, By Country, 2023 - 2030, USD Million
• TABLE 53 North America Online Pharmacies Market, By Country, 2019 - 2022, USD Million
• TABLE 54 North America Online Pharmacies Market, By Country, 2023 - 2030, USD Million
• TABLE 55 North America Pigmentation Disorder Treatment Market, By Country, 2019 - 2022, USD Million
• TABLE 56 North America Pigmentation Disorder Treatment Market, By Country, 2023 - 2030, USD Million
• TABLE 57 US Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 58 US Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 59 US Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
• TABLE 60 US Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
• TABLE 61 US Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
• TABLE 62 US Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
• TABLE 63 US Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
• TABLE 64 US Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
• TABLE 65 Canada Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 66 Canada Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 67 Canada Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
• TABLE 68 Canada Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
• TABLE 69 Canada Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
• TABLE 70 Canada Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
• TABLE 71 Canada Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
• TABLE 72 Canada Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
• TABLE 73 Mexico Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 74 Mexico Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 75 Mexico Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
• TABLE 76 Mexico Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
• TABLE 77 Mexico Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
• TABLE 78 Mexico Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
• TABLE 79 Mexico Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
• TABLE 80 Mexico Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
• TABLE 81 Rest of North America Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 82 Rest of North America Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 83 Rest of North America Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
• TABLE 84 Rest of North America Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
• TABLE 85 Rest of North America Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
• TABLE 86 Rest of North America Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
• TABLE 87 Rest of North America Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
• TABLE 88 Rest of North America Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
• TABLE 89 Europe Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 90 Europe Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 91 Europe Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
• TABLE 92 Europe Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
• TABLE 93 Europe Vitiligo Market, By Country, 2019 - 2022, USD Million
• TABLE 94 Europe Vitiligo Market, By Country, 2023 - 2030, USD Million
• TABLE 95 Europe Melasma Market, By Country, 2019 - 2022, USD Million
• TABLE 96 Europe Melasma Market, By Country, 2023 - 2030, USD Million
• TABLE 97 Europe Others Market, By Country, 2019 - 2022, USD Million
• TABLE 98 Europe Others Market, By Country, 2023 - 2030, USD Million
• TABLE 99 Europe Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
• TABLE 100 Europe Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
• TABLE 101 Europe Corticosteroids Market, By Country, 2019 - 2022, USD Million
• TABLE 102 Europe Corticosteroids Market, By Country, 2023 - 2030, USD Million
• TABLE 103 Europe Calcineurin Inhibitor Market, By Country, 2019 - 2022, USD Million
• TABLE 104 Europe Calcineurin Inhibitor Market, By Country, 2023 - 2030, USD Million
• TABLE 105 Europe Others Market, By Country, 2019 - 2022, USD Million
• TABLE 106 Europe Others Market, By Country, 2023 - 2030, USD Million
• TABLE 107 Europe Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
• TABLE 108 Europe Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
• TABLE 109 Europe Drug Store & Retail Pharmacies Market, By Country, 2019 - 2022, USD Million
• TABLE 110 Europe Drug Store & Retail Pharmacies Market, By Country, 2023 - 2030, USD Million
• TABLE 111 Europe Hospital Pharmacies Market, By Country, 2019 - 2022, USD Million
• TABLE 112 Europe Hospital Pharmacies Market, By Country, 2023 - 2030, USD Million
• TABLE 113 Europe Online Pharmacies Market, By Country, 2019 - 2022, USD Million
• TABLE 114 Europe Online Pharmacies Market, By Country, 2023 - 2030, USD Million
• TABLE 115 Europe Pigmentation Disorder Treatment Market, By Country, 2019 - 2022, USD Million
• TABLE 116 Europe Pigmentation Disorder Treatment Market, By Country, 2023 - 2030, USD Million
• TABLE 117 Germany Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 118 Germany Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 119 Germany Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
• TABLE 120 Germany Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
• TABLE 121 Germany Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
• TABLE 122 Germany Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
• TABLE 123 Germany Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
• TABLE 124 Germany Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
• TABLE 125 UK Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 126 UK Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 127 UK Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
• TABLE 128 UK Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
• TABLE 129 UK Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
• TABLE 130 UK Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
• TABLE 131 UK Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
• TABLE 132 UK Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
• TABLE 133 France Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 134 France Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 135 France Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
• TABLE 136 France Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
• TABLE 137 France Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
• TABLE 138 France Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
• TABLE 139 France Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
• TABLE 140 France Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
• TABLE 141 Russia Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 142 Russia Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 143 Russia Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
• TABLE 144 Russia Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
• TABLE 145 Russia Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
• TABLE 146 Russia Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
• TABLE 147 Russia Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
• TABLE 148 Russia Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
• TABLE 149 Spain Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 150 Spain Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 151 Spain Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
• TABLE 152 Spain Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
• TABLE 153 Spain Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
• TABLE 154 Spain Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
• TABLE 155 Spain Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
• TABLE 156 Spain Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
• TABLE 157 Italy Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 158 Italy Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 159 Italy Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
• TABLE 160 Italy Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
• TABLE 161 Italy Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
• TABLE 162 Italy Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
• TABLE 163 Italy Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
• TABLE 164 Italy Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
• TABLE 165 Rest of Europe Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 166 Rest of Europe Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 167 Rest of Europe Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
• TABLE 168 Rest of Europe Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
• TABLE 169 Rest of Europe Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
• TABLE 170 Rest of Europe Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
• TABLE 171 Rest of Europe Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
• TABLE 172 Rest of Europe Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
• TABLE 173 Asia Pacific Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 174 Asia Pacific Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 175 Asia Pacific Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
• TABLE 176 Asia Pacific Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
• TABLE 177 Asia Pacific Vitiligo Market, By Country, 2019 - 2022, USD Million
• TABLE 178 Asia Pacific Vitiligo Market, By Country, 2023 - 2030, USD Million
• TABLE 179 Asia Pacific Melasma Market, By Country, 2019 - 2022, USD Million
• TABLE 180 Asia Pacific Melasma Market, By Country, 2023 - 2030, USD Million
• TABLE 181 Asia Pacific Others Market, By Country, 2019 - 2022, USD Million
• TABLE 182 Asia Pacific Others Market, By Country, 2023 - 2030, USD Million
• TABLE 183 Asia Pacific Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
• TABLE 184 Asia Pacific Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
• TABLE 185 Asia Pacific Corticosteroids Market, By Country, 2019 - 2022, USD Million
• TABLE 186 Asia Pacific Corticosteroids Market, By Country, 2023 - 2030, USD Million
• TABLE 187 Asia Pacific Calcineurin Inhibitor Market, By Country, 2019 - 2022, USD Million
• TABLE 188 Asia Pacific Calcineurin Inhibitor Market, By Country, 2023 - 2030, USD Million
• TABLE 189 Asia Pacific Others Market, By Country, 2019 - 2022, USD Million
• TABLE 190 Asia Pacific Others Market, By Country, 2023 - 2030, USD Million
• TABLE 191 Asia Pacific Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
• TABLE 192 Asia Pacific Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
• TABLE 193 Asia Pacific Drug Store & Retail Pharmacies Market, By Country, 2019 - 2022, USD Million
• TABLE 194 Asia Pacific Drug Store & Retail Pharmacies Market, By Country, 2023 - 2030, USD Million
• TABLE 195 Asia Pacific Hospital Pharmacies Market, By Country, 2019 - 2022, USD Million
• TABLE 196 Asia Pacific Hospital Pharmacies Market, By Country, 2023 - 2030, USD Million
• TABLE 197 Asia Pacific Online Pharmacies Market, By Country, 2019 - 2022, USD Million
• TABLE 198 Asia Pacific Online Pharmacies Market, By Country, 2023 - 2030, USD Million
• TABLE 199 Asia Pacific Pigmentation Disorder Treatment Market, By Country, 2019 - 2022, USD Million
• TABLE 200 Asia Pacific Pigmentation Disorder Treatment Market, By Country, 2023 - 2030, USD Million
• TABLE 201 China Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 202 China Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 203 China Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
• TABLE 204 China Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
• TABLE 205 China Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
• TABLE 206 China Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
• TABLE 207 China Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
• TABLE 208 China Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
• TABLE 209 Japan Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 210 Japan Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 211 Japan Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
• TABLE 212 Japan Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
• TABLE 213 Japan Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
• TABLE 214 Japan Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
• TABLE 215 Japan Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
• TABLE 216 Japan Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
• TABLE 217 India Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 218 India Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 219 India Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
• TABLE 220 India Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
• TABLE 221 India Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
• TABLE 222 India Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
• TABLE 223 India Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
• TABLE 224 India Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
• TABLE 225 South Korea Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 226 South Korea Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 227 South Korea Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
• TABLE 228 South Korea Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
• TABLE 229 South Korea Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
• TABLE 230 South Korea Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
• TABLE 231 South Korea Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
• TABLE 232 South Korea Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
• TABLE 233 Singapore Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 234 Singapore Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 235 Singapore Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
• TABLE 236 Singapore Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
• TABLE 237 Singapore Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
• TABLE 238 Singapore Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
• TABLE 239 Singapore Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
• TABLE 240 Singapore Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
• TABLE 241 Malaysia Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 242 Malaysia Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 243 Malaysia Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
• TABLE 244 Malaysia Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
• TABLE 245 Malaysia Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
• TABLE 246 Malaysia Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
• TABLE 247 Malaysia Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
• TABLE 248 Malaysia Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
• TABLE 249 Rest of Asia Pacific Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 250 Rest of Asia Pacific Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 251 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
• TABLE 252 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
• TABLE 253 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
• TABLE 254 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
• TABLE 255 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
• TABLE 256 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million

The Global Pigmentation Disorder Treatment Market size is expected to reach $1.2 billion by 2030, rising at a market growth of 4.8% CAGR during the forecast period.

There has been a significant increase in awareness regarding pigmentation disorders, skin health, and skincare in the APAC region. Consequently, the APAC region registered $212.6 million revenue in the market in 2022. People are becoming more conscious of their skin's appearance and health, increasing their willingness to seek treatment for pigmentation issues. Rapid urbanization in many APAC countries has brought changes in lifestyle and exposure to environmental factors that can exacerbate pigmentation disorders. Urban populations often have more access to healthcare facilities, including dermatologists. APAC countries often experience high levels of sunlight, which can contribute to pigmentation disorders such as melasma and solar lentigines. This has prompted people to seek treatments like sunscreens and laser therapy. Some of the factors impacting the market are growing awareness of skin health, advancements in treatment modalities, and limited efficacy of currently available treatments.

Greater awareness of the importance of skin health and aesthetics has prompted more individuals to seek treatment for pigmentation issues. People are becoming more proactive about addressing skin concerns. As individuals become more informed about skin health, they are more likely to recognize the early signs of pigmentation disorders. This can lead to earlier diagnosis and intervention, potentially improving treatment outcomes. Advances in dermatological treatments have improved the effectiveness and safety of pigmentation disorder treatments. Innovative technologies offer better outcomes, such as laser therapy, chemical peels, microneedling, and topical formulations. Advancements in treatment modalities often result in more effective treatments in addressing pigmentation disorders. For example, newer laser technologies and techniques can target pigmentation with greater precision, leading to improved outcomes. Thus, the advancements in treatment modalities benefit patients by providing more effective and comfortable treatment options and driving growth in the market.

However, the limited efficacy of currently available pigmentation disorder treatment options is a significant concern in the field of dermatology. One of the primary factors contributing to this limitation is the complex and multifaceted nature of these conditions. Pigmentation disorders often involve intricate mechanisms within the skin, making them resistant to straightforward treatment approaches. As a result, there is no one-size-fits-all solution, and the quest for effective treatments continues to challenge dermatologists and researchers. Moreover, the pandemic disrupted global supply chains, including skin care products and dermatological equipment production and distribution. This led to shortages of certain treatment products and delayed the availability of new treatments. Economic uncertainties caused by the pandemic led some individuals to reduce discretionary spending, including spending on cosmetic and dermatological treatments. This economic impact affected the affordability and demand for pigmentation disorder treatments.

Type Outlook

By type, the market is categorized into vitiligo, melasma, and others. In 2022, the vitiligo segment held the highest revenue share in the market. Vitiligo is a specific pigmentation disorder characterized by the loss of melanocytes (pigment-producing cells) in certain areas of the skin, resulting in the development of white patches. The treatment of vitiligo is a significant component of the broader market. Topical corticosteroids, calcineurin inhibitors, and topical calcipotriene commonly treat vitiligo. These products are directly applied to the afflicted areas of the skin to reduce inflammation and encourage repigmentation. They are an essential part of the market.

Treatment Outlook

Based on treatment, the market is segmented into corticosteroids, calcineurin inhibitor, and others. The calcineurin inhibitor segment garnered a significant revenue share in the market in 2022. Calcineurin inhibitors have effectively treated pigmentation disorders like vitiligo, particularly in areas where corticosteroids may be less suitable due to skin thinning or other concerns. These medications work by modulating the immune response in the skin, which can be particularly useful for pigmentation disorders with autoimmune or inflammatory components. Calcineurin inhibitors are generally considered safe for long-term use on delicate or sensitive skin areas, such as the face and genital area, where corticosteroids might carry a higher risk of side effects.

Distribution Channel Outlook

On the basis of distribution channel, the market is divided into hospital pharmacies, drug store & retail pharmacies, and online pharmacies. The drug store and retail pharmacies segment recorded the maximum revenue share in the market in 2022. Drug stores and retail pharmacies typically offer a range of OTC skincare products, including those designed for pigmentation disorders. This increased accessibility allows individuals to explore and try certain treatments without a prescription, potentially boosting sales of these products. Many prescription pigmentation disorder treatments, such as topical corticosteroids, calcineurin inhibitors, and specialized creams, can be dispensed by retail pharmacies.

Region Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. Dermatological clinics and medical spas are key providers of pigmentation disorder treatments in North America. These facilities offered various services, including consultations, in-office procedures, and skincare products. The well-established healthcare infrastructure in North America, including many dermatology clinics and well-trained dermatologists, supported the market's growth. Advancements in laser technology and innovative treatment devices enhanced the efficacy and safety of pigmentation disorder treatments in North America.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Bausch Health Companies Inc, Glenmark Pharmaceuticals Limited, Obagi Cosmeceuticals LLC, AbbVie, Inc., Dermavant Sciences, Inc. (Roivant Sciences Ltd.), Incyte Corporation, Dr. Reddy's Laboratories Ltd., Galderma S.A., Viatris, Inc. (Mylan N.V.), and Pfizer, Inc.

Scope of the Study

Market Segments covered in the Report:

By Type

• Vitiligo
• Melasma
• Others

By Treatment

• Corticosteroids
• Calcineurin Inhibitor
• Others

By Distribution Channel

• Drug Store & Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Bausch Health Companies Inc
• Glenmark Pharmaceuticals Limited
• Obagi Cosmeceuticals LLC
• AbbVie, Inc.
• Dermavant Sciences, Inc. (Roivant Sciences Ltd.)
• Incyte Corporation
• Dr. Reddy's Laboratories Ltd.
• Galderma S.A.
• Viatris, Inc. (Mylan N.V.)
• Pfizer, Inc.

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Pigmentation Disorder Treatment Market, by Type
  • 1.4.2 Global Pigmentation Disorder Treatment Market, by Treatment
  • 1.4.3 Global Pigmentation Disorder Treatment Market, by Distribution Channel
  • 1.4.4 Global Pigmentation Disorder Treatment Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
• 3.3 Porter Five Forces Analysis

Chapter 4. Global Pigmentation Disorder Treatment Market, By Type

• 4.1 Global Vitiligo Market, By Region
• 4.2 Global Melasma Market, By Region
• 4.3 Global Others Market, By Region

Chapter 5. Global Pigmentation Disorder Treatment Market, By Treatment

• 5.1 Global Corticosteroids Market, By Region
• 5.2 Global Calcineurin Inhibitor Market, By Region
• 5.3 Global Others Market, By Region

Chapter 6. Global Pigmentation Disorder Treatment Market, By Distribution Channel

• 6.1 Global Drug Store & Retail Pharmacies Market, By Region
• 6.2 Global Hospital Pharmacies Market, By Region
• 6.3 Global Online Pharmacies Market, By Region

Chapter 7. Global Pigmentation Disorder Treatment Market, By Region

• 7.1 North America Pigmentation Disorder Treatment Market
  • 7.1.1 North America Pigmentation Disorder Treatment Market, By Type
    • 7.1.1.1 North America Vitiligo Market, By Country
    • 7.1.1.2 North America Melasma Market, By Country
    • 7.1.1.3 North America Others Market, By Country
  • 7.1.2 North America Pigmentation Disorder Treatment Market, By Treatment
    • 7.1.2.1 North America Corticosteroids Market, By Country
    • 7.1.2.2 North America Calcineurin Inhibitor Market, By Country
    • 7.1.2.3 North America Others Market, By Country
  • 7.1.3 North America Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.1.3.1 North America Drug Store & Retail Pharmacies Market, By Country
    • 7.1.3.2 North America Hospital Pharmacies Market, By Country
    • 7.1.3.3 North America Online Pharmacies Market, By Country
  • 7.1.4 North America Pigmentation Disorder Treatment Market, By Country
    • 7.1.4.1 US Pigmentation Disorder Treatment Market
      • 7.1.4.1.1 US Pigmentation Disorder Treatment Market, By Type
      • 7.1.4.1.2 US Pigmentation Disorder Treatment Market, By Treatment
      • 7.1.4.1.3 US Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.1.4.2 Canada Pigmentation Disorder Treatment Market
      • 7.1.4.2.1 Canada Pigmentation Disorder Treatment Market, By Type
      • 7.1.4.2.2 Canada Pigmentation Disorder Treatment Market, By Treatment
      • 7.1.4.2.3 Canada Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.1.4.3 Mexico Pigmentation Disorder Treatment Market
      • 7.1.4.3.1 Mexico Pigmentation Disorder Treatment Market, By Type
      • 7.1.4.3.2 Mexico Pigmentation Disorder Treatment Market, By Treatment
      • 7.1.4.3.3 Mexico Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.1.4.4 Rest of North America Pigmentation Disorder Treatment Market
      • 7.1.4.4.1 Rest of North America Pigmentation Disorder Treatment Market, By Type
      • 7.1.4.4.2 Rest of North America Pigmentation Disorder Treatment Market, By Treatment
      • 7.1.4.4.3 Rest of North America Pigmentation Disorder Treatment Market, By Distribution Channel
• 7.2 Europe Pigmentation Disorder Treatment Market
  • 7.2.1 Europe Pigmentation Disorder Treatment Market, By Type
    • 7.2.1.1 Europe Vitiligo Market, By Country
    • 7.2.1.2 Europe Melasma Market, By Country
    • 7.2.1.3 Europe Others Market, By Country
  • 7.2.2 Europe Pigmentation Disorder Treatment Market, By Treatment
    • 7.2.2.1 Europe Corticosteroids Market, By Country
    • 7.2.2.2 Europe Calcineurin Inhibitor Market, By Country
    • 7.2.2.3 Europe Others Market, By Country
  • 7.2.3 Europe Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.2.3.1 Europe Drug Store & Retail Pharmacies Market, By Country
    • 7.2.3.2 Europe Hospital Pharmacies Market, By Country
    • 7.2.3.3 Europe Online Pharmacies Market, By Country
  • 7.2.4 Europe Pigmentation Disorder Treatment Market, By Country
    • 7.2.4.1 Germany Pigmentation Disorder Treatment Market
      • 7.2.4.1.1 Germany Pigmentation Disorder Treatment Market, By Type
      • 7.2.4.1.2 Germany Pigmentation Disorder Treatment Market, By Treatment
      • 7.2.4.1.3 Germany Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.2.4.2 UK Pigmentation Disorder Treatment Market
      • 7.2.4.2.1 UK Pigmentation Disorder Treatment Market, By Type
      • 7.2.4.2.2 UK Pigmentation Disorder Treatment Market, By Treatment
      • 7.2.4.2.3 UK Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.2.4.3 France Pigmentation Disorder Treatment Market
      • 7.2.4.3.1 France Pigmentation Disorder Treatment Market, By Type
      • 7.2.4.3.2 France Pigmentation Disorder Treatment Market, By Treatment
      • 7.2.4.3.3 France Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.2.4.4 Russia Pigmentation Disorder Treatment Market
      • 7.2.4.4.1 Russia Pigmentation Disorder Treatment Market, By Type
      • 7.2.4.4.2 Russia Pigmentation Disorder Treatment Market, By Treatment
      • 7.2.4.4.3 Russia Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.2.4.5 Spain Pigmentation Disorder Treatment Market
      • 7.2.4.5.1 Spain Pigmentation Disorder Treatment Market, By Type
      • 7.2.4.5.2 Spain Pigmentation Disorder Treatment Market, By Treatment
      • 7.2.4.5.3 Spain Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.2.4.6 Italy Pigmentation Disorder Treatment Market
      • 7.2.4.6.1 Italy Pigmentation Disorder Treatment Market, By Type
      • 7.2.4.6.2 Italy Pigmentation Disorder Treatment Market, By Treatment
      • 7.2.4.6.3 Italy Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.2.4.7 Rest of Europe Pigmentation Disorder Treatment Market
      • 7.2.4.7.1 Rest of Europe Pigmentation Disorder Treatment Market, By Type
      • 7.2.4.7.2 Rest of Europe Pigmentation Disorder Treatment Market, By Treatment
      • 7.2.4.7.3 Rest of Europe Pigmentation Disorder Treatment Market, By Distribution Channel
• 7.3 Asia Pacific Pigmentation Disorder Treatment Market
  • 7.3.1 Asia Pacific Pigmentation Disorder Treatment Market, By Type
    • 7.3.1.1 Asia Pacific Vitiligo Market, By Country
    • 7.3.1.2 Asia Pacific Melasma Market, By Country
    • 7.3.1.3 Asia Pacific Others Market, By Country
  • 7.3.2 Asia Pacific Pigmentation Disorder Treatment Market, By Treatment
    • 7.3.2.1 Asia Pacific Corticosteroids Market, By Country
    • 7.3.2.2 Asia Pacific Calcineurin Inhibitor Market, By Country
    • 7.3.2.3 Asia Pacific Others Market, By Country
  • 7.3.3 Asia Pacific Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.3.3.1 Asia Pacific Drug Store & Retail Pharmacies Market, By Country
    • 7.3.3.2 Asia Pacific Hospital Pharmacies Market, By Country
    • 7.3.3.3 Asia Pacific Online Pharmacies Market, By Country
  • 7.3.4 Asia Pacific Pigmentation Disorder Treatment Market, By Country
    • 7.3.4.1 China Pigmentation Disorder Treatment Market
      • 7.3.4.1.1 China Pigmentation Disorder Treatment Market, By Type
      • 7.3.4.1.2 China Pigmentation Disorder Treatment Market, By Treatment
      • 7.3.4.1.3 China Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.3.4.2 Japan Pigmentation Disorder Treatment Market
      • 7.3.4.2.1 Japan Pigmentation Disorder Treatment Market, By Type
      • 7.3.4.2.2 Japan Pigmentation Disorder Treatment Market, By Treatment
      • 7.3.4.2.3 Japan Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.3.4.3 India Pigmentation Disorder Treatment Market
      • 7.3.4.3.1 India Pigmentation Disorder Treatment Market, By Type
      • 7.3.4.3.2 India Pigmentation Disorder Treatment Market, By Treatment
      • 7.3.4.3.3 India Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.3.4.4 South Korea Pigmentation Disorder Treatment Market
      • 7.3.4.4.1 South Korea Pigmentation Disorder Treatment Market, By Type
      • 7.3.4.4.2 South Korea Pigmentation Disorder Treatment Market, By Treatment
      • 7.3.4.4.3 South Korea Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.3.4.5 Singapore Pigmentation Disorder Treatment Market
      • 7.3.4.5.1 Singapore Pigmentation Disorder Treatment Market, By Type
      • 7.3.4.5.2 Singapore Pigmentation Disorder Treatment Market, By Treatment
      • 7.3.4.5.3 Singapore Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.3.4.6 Malaysia Pigmentation Disorder Treatment Market
      • 7.3.4.6.1 Malaysia Pigmentation Disorder Treatment Market, By Type
      • 7.3.4.6.2 Malaysia Pigmentation Disorder Treatment Market, By Treatment
      • 7.3.4.6.3 Malaysia Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.3.4.7 Rest of Asia Pacific Pigmentation Disorder Treatment Market
      • 7.3.4.7.1 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Type
      • 7.3.4.7.2 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Treatment
      • 7.3.4.7.3 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Distribution Channel
• 7.4 LAMEA Pigmentation Disorder Treatment Market
  • 7.4.1 LAMEA Pigmentation Disorder Treatment Market, By Type
    • 7.4.1.1 LAMEA Vitiligo Market, By Country
    • 7.4.1.2 LAMEA Melasma Market, By Country
    • 7.4.1.3 LAMEA Others Market, By Country
  • 7.4.2 LAMEA Pigmentation Disorder Treatment Market, By Treatment
    • 7.4.2.1 LAMEA Corticosteroids Market, By Country
    • 7.4.2.2 LAMEA Calcineurin Inhibitor Market, By Country
    • 7.4.2.3 LAMEA Others Market, By Country
  • 7.4.3 LAMEA Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.4.3.1 LAMEA Drug Store & Retail Pharmacies Market, By Country
    • 7.4.3.2 LAMEA Hospital Pharmacies Market, By Country
    • 7.4.3.3 LAMEA Online Pharmacies Market, By Country
  • 7.4.4 LAMEA Pigmentation Disorder Treatment Market, By Country
    • 7.4.4.1 Brazil Pigmentation Disorder Treatment Market
      • 7.4.4.1.1 Brazil Pigmentation Disorder Treatment Market, By Type
      • 7.4.4.1.2 Brazil Pigmentation Disorder Treatment Market, By Treatment
      • 7.4.4.1.3 Brazil Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.4.4.2 Argentina Pigmentation Disorder Treatment Market
      • 7.4.4.2.1 Argentina Pigmentation Disorder Treatment Market, By Type
      • 7.4.4.2.2 Argentina Pigmentation Disorder Treatment Market, By Treatment
      • 7.4.4.2.3 Argentina Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.4.4.3 UAE Pigmentation Disorder Treatment Market
      • 7.4.4.3.1 UAE Pigmentation Disorder Treatment Market, By Type
      • 7.4.4.3.2 UAE Pigmentation Disorder Treatment Market, By Treatment
      • 7.4.4.3.3 UAE Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.4.4.4 Saudi Arabia Pigmentation Disorder Treatment Market
      • 7.4.4.4.1 Saudi Arabia Pigmentation Disorder Treatment Market, By Type
      • 7.4.4.4.2 Saudi Arabia Pigmentation Disorder Treatment Market, By Treatment
      • 7.4.4.4.3 Saudi Arabia Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.4.4.5 South Africa Pigmentation Disorder Treatment Market
      • 7.4.4.5.1 South Africa Pigmentation Disorder Treatment Market, By Type
      • 7.4.4.5.2 South Africa Pigmentation Disorder Treatment Market, By Treatment
      • 7.4.4.5.3 South Africa Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.4.4.6 Nigeria Pigmentation Disorder Treatment Market
      • 7.4.4.6.1 Nigeria Pigmentation Disorder Treatment Market, By Type
      • 7.4.4.6.2 Nigeria Pigmentation Disorder Treatment Market, By Treatment
      • 7.4.4.6.3 Nigeria Pigmentation Disorder Treatment Market, By Distribution Channel
    • 7.4.4.7 Rest of LAMEA Pigmentation Disorder Treatment Market
      • 7.4.4.7.1 Rest of LAMEA Pigmentation Disorder Treatment Market, By Type
      • 7.4.4.7.2 Rest of LAMEA Pigmentation Disorder Treatment Market, By Treatment
      • 7.4.4.7.3 Rest of LAMEA Pigmentation Disorder Treatment Market, By Distribution Channel

Chapter 8. Company Profiles

• 8.1 Bausch Health Companies Inc
  • 8.1.1 Company Overview
  • 8.1.2 Financial Analysis
  • 8.1.3 Segmental and Regional Analysis
  • 8.1.4 Research & Development Expenses
  • 8.1.5 SWOT Analysis
• 8.2 Glenmark Pharmaceuticals Limited
  • 8.2.1 Company Overview
  • 8.2.2 Financial Analysis
  • 8.2.3 Regional Analysis
  • 8.2.4 Research & Development Expenses
  • 8.2.5 SWOT Analysis
• 8.3 Obagi Cosmeceuticals LLC
  • 8.3.1 Company Overview
  • 8.3.2 SWOT Analysis
• 8.4 AbbVie, Inc.
  • 8.4.1 Company Overview
  • 8.4.2 Financial Analysis
  • 8.4.3 Regional Analysis
  • 8.4.4 Research & Development Expense
• 8.5 Dermavant Sciences, Inc. (Roivant Sciences Ltd.)
  • 8.5.1 Company Overview
  • 8.5.2 Financial Analysis
  • 8.5.3 Research & Development Expenses
  • 8.5.4 SWOT Analysis
• 8.6 Incyte Corporation
  • 8.6.1 Company Overview
  • 8.6.2 Financial Analysis
  • 8.6.3 Research & Development Expenses
    • 8.6.3.1 Acquisition and Mergers:
    • 8.6.3.2 Trials and Approvals:
  • 8.6.4 SWOT Analysis
• 8.7 Dr. Reddy's Laboratories Ltd.
  • 8.7.1 Company Overview
  • 8.7.2 Financial Analysis
  • 8.7.3 Segmental and Regional Analysis
  • 8.7.4 Research & Development Expense
  • 8.7.5 SWOT Analysis
• 8.8 Galderma S.A.
  • 8.8.1 Company Overview
• 8.9 Viatris, Inc. (Mylan N.V.)
  • 8.9.1 Company Overview
  • 8.9.2 Financial Analysis
  • 8.9.3 Segmental Analysis
  • 8.9.4 Research & Development Expense
  • 8.9.5 SWOT Analysis
• 8.10. Pfizer, Inc.
  • 8.10.1 Company Overview
  • 8.10.2 Financial Analysis
  • 8.10.3 Regional & Segmental Analysis
  • 8.10.4 Research & Development Expense
  • 8.10.5 SWOT Analysis

Chapter 9. Winning imperatives of Pigmentation Disorder Treatment Market